The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG

Trial Profile

The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2009

At a glance

  • Drugs Mitumomab (Primary)
  • Indications Small cell lung cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms SILVA
  • Most Recent Events

    • 08 Feb 2009 Last checked against ClinicalTrials.gov record (NCT00006352).
    • 08 Feb 2009 Last checked against ClinicalTrials.gov record (NCT00006352).
    • 06 Feb 2009 Last checked against ClinicalTrials.gov record (NCT00003279).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top